RT Journal Article
SR Electronic
T1 Leukocyte Telomere Length and Cardiac Structure and Function: A Mendelian Randomization Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.13.23295516
DO 10.1101/2023.09.13.23295516
A1 Salih, Ahmed
A1 Boscolo Galazzo, Ilaria
A1 Menegaz, Gloria
A1 Altmann, André
YR 2023
UL http://medrxiv.org/content/early/2023/09/14/2023.09.13.23295516.abstract
AB Existing research demonstrates association of shorter telomere length (TL) with increased risk of agerelated health outcomes including cardiovascular diseases. However, the direct causality of these relationships is not definitively established. Cardiovascular aging at an organ-level may be captured using image derived phenotypes (IDPs) of cardiac anatomy and function. In the current study, we use two-sample Mendelian Randomization (MR) to assess the causal link between TL and 54 cardiac magnetic resonance imaging (CMR) measures representing structure and function across the four cardiac chambers. Genetically predicted shorter TL was causally linked to smaller ventricular cavity sizes including left ventricular end-systolic volume (LVESV), left ventricular end-diastolic volume (LVEDV), lower left ventricular mass (LVM) and pulmonary artery. The association with LVM (β = 0.217, PFDR = 0.016) remained significant after multiple testing adjustment, whilst other associations were attenuated. Our findings support a causal role for shorter TL and faster cardiac aging, with the most prominent relationship with LVM.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAhmed Salih is supported by a British Heart Foundation project grant (PG/21/10619). Ilaria Boscolo Galazzo and Gloria Menegaz acknowledges support from Fondazione CariVerona (Bando Ricerca Scientifica di Eccellenza 2018, EDIPO project, num. 2018.0855.2019) and MIUR D.M. 737/2021 "AI4Health: empowering neurosciences with eXplainable AI methods".Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis study did not use any raw data, it rather used GWAS summary statistics of several studies that are publicly available